Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China flag China · Delayed Price · Currency is CNY
50.45
-1.25 (-2.42%)
May 14, 2026, 4:00 PM EDT

Cofoe Medical Technology Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,4931,4221,2791,5691,4501,989
Trading Asset Securities
1,1781,0171,357851.31,2431,537
Cash & Short-Term Investments
2,6712,4392,6362,4212,6933,527
Cash Growth
4.48%-7.50%8.90%-10.12%-23.63%533.03%
Accounts Receivable
460.53444.79401.84486617.22362.02
Other Receivables
66.6261.3747.5230.6346.1532.42
Receivables
527.15506.15449.36516.63663.37394.44
Inventory
676.86675.5659.58634.72529.36480.75
Other Current Assets
289.39215.14180.45258.66314.63117.11
Total Current Assets
4,1643,8353,9253,8314,2014,519
Property, Plant & Equipment
1,7121,7501,6371,6961,598879.7
Long-Term Investments
240.51237.3461.4364.935.265.28
Goodwill
368.91368.91364.34242.41230.548.59
Other Intangible Assets
275.7278.13235.93240.55248.25202.27
Long-Term Accounts Receivable
-4.93----
Long-Term Deferred Tax Assets
41.3440.5344.9734.7231.4212.61
Long-Term Deferred Charges
61.4263.5152.850.9260.3247.75
Other Long-Term Assets
49.2549.94100.2384.1135.9592.07
Total Assets
6,9136,6296,4236,2446,4115,807
Accounts Payable
622.71639.05467.65482.97634.89448.1
Accrued Expenses
39.67118.195.8992.09144.4558.84
Short-Term Debt
911.61574.75548.61402.43282.7483.07
Current Portion of Long-Term Debt
43.73125.08114.011213.8110
Current Portion of Leases
-58.3154.1255.0151.6941.89
Current Income Taxes Payable
43.33.917.83.7628.4723.31
Current Unearned Revenue
33.2829.312.1316.848.9810
Other Current Liabilities
315.7540.2761.5121.3122.567.38
Total Current Liabilities
2,0101,5891,3621,0861,188682.58
Long-Term Debt
--125.1794.130.035
Long-Term Leases
65.7468.0461.4877.2484.5593.19
Long-Term Unearned Revenue
59.558.5955.755.6251.756.84
Pension & Post-Retirement Benefits
-2.88----
Long-Term Deferred Tax Liabilities
7.387.7515.0315.716.684.36
Other Long-Term Liabilities
2.82-1.216.947.41-
Total Liabilities
2,1451,7261,6201,3361,378841.97
Common Stock
208.9208.9209.09209.24208.49160
Additional Paid-In Capital
3,9323,9263,9313,9333,9133,917
Retained Earnings
735.31874.29868.67923.4914.88869.8
Treasury Stock
-140.47-140.47-212.12-166.93-15.74-
Comprehensive Income & Other
-4.05-1.55----
Total Common Equity
4,7324,8674,7974,8995,0204,947
Minority Interest
36.0636.035.75912.5717.94
Shareholders' Equity
4,7684,9034,8024,9085,0334,965
Total Liabilities & Equity
6,9136,6296,4236,2446,4115,807
Total Debt
1,021826.18903.4640.77462.82233.15
Net Cash (Debt)
1,6501,6121,7331,7802,2313,293
Net Cash Growth
-6.30%-6.95%-2.65%-20.20%-32.27%1133.06%
Net Cash Per Share
8.017.858.428.6910.7020.00
Filing Date Shares Outstanding
205.85203.2203.39203.7203.94208
Total Common Shares Outstanding
205.85203.2203.39205.04203.94208
Working Capital
2,1542,2472,5642,7443,0133,836
Book Value Per Share
22.9923.9523.5823.8924.6223.78
Tangible Book Value
4,0874,2204,1964,4164,5424,696
Tangible Book Value Per Share
19.8620.7720.6321.5422.2722.58
Buildings
-1,2981,2321,2481,10771.62
Machinery
-520.6479.08407.64259.17193.3
Construction In Progress
-138.6350.1349.33171.39508.49
Source: S&P Global Market Intelligence. Standard template. Financial Sources.